LRMR
Larimar Therapeutics, Inc.$4.38-0.07 (-1.46%)Prev Close$4.44·MCap$388.5M·P/E—·Vol1.15M·Yield—
▲
Buys (12M)
5
$55.55M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$55.55M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Larimar Therapeutics, Inc. (LRMR) has been exclusively buying, with 5 insider purchases totaling $55.55M and 0 insider sales totaling $0.00. The most recent insider transaction was by Flynn James E (director, 10 percent owner, other: * Director by Deputization), who purchased $25.00M worth of shares on Mar 2, 2026. Larimar Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $388.5M.
LRMR Insider Trading Activity
LRMR Insider Buying Activity
The following table shows recent insider purchases of Larimar Therapeutics, Inc. (LRMR) stock reported via SEC Form 4 filings.
LRMR Insider Selling Activity
The following table shows recent insider sales of Larimar Therapeutics, Inc. (LRMR) stock reported via SEC Form 4 filings.
No insider selling activity found for LRMR in the last 12 months.